Paul Tudor Jones Codexis, Inc. Transaction History
Tudor Investment Corp Et Al
- $200 Billion
- Q3 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Codexis, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 537,833 shares of CDXS stock, worth $887,424. This represents 0.0% of its overall portfolio holdings.
Number of Shares
537,833Holding current value
$887,424% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding CDXS
# of Institutions
143Shares Held
68.9MCall Options Held
42KPut Options Held
31.8K-
Opaleye Management Inc. Boston, MA12.8MShares$21.1 Million5.2% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$11.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.67MShares$7.71 Million0.0% of portfolio
-
Abrdn PLC4.09MShares$6.75 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.07MShares$6.71 Million0.0% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $108M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...